Article
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jan 2008
Ferraris Olivier, Lina Bruno
Abstract excerpt
Influenza constitutes one of the most important upper respiratory tract infections regarding morbidity, and mortality. Prevention and treatment of influenza rely on inactivated vaccines and antiviral drugs. Zanamivir and Oseltamivir, the currently available influenza neuraminidase inhibitors (NAI) can be used in clinical practice for the treatment of influenza infection. These drugs have also shown their efficacy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
